05/07/2026
At SupplySide Connect, Dr. Suresh Lakshmikanthan is challenging one of the biggest assumptions in the ashwagandha category: that more is better.
In his latest interview with Nicholas Senior Editor at Nutritional Outlook, the focus is on potency—not dose. Ashwa.30® is designed by Natural Remedies Human Health Care to deliver clinical efficacy at just 30 mg—a fraction of the traditional 300–600 mg standard—by concentrating multiple active compounds within the plant through bioactive optimization.
What makes that possible is dual standardization: withanolides for stress modulation and a proprietary ATP-active fraction to support mitochondrial function, energy metabolism, and endurance.
The result? A more efficient, targeted approach to formulation—supported by data showing improvements in VO2 max and reductions in muscle damage markers.
This isn’t just incremental innovation—it’s a rethink of how adaptogens are formulated for performance, energy, and real-world application.
Less dose. More precision.
At SupplySide Connect New Jersey, Suresh Lakshmikanthan, PhD, Natural Remedies’ chief business officer, explains how dual-standardized Ashwa-30 leverages ATP-active compounds and withanolides to deliver energy, endurance, and metabolic benefits at just 30 mg.